INSIDER/TRADES Sign in Get started

Arkin Moshe

Insider CIK 1321178 · ODYS Director, 10% owner · KROS 10% owner · HOWL 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ODYS Odysight.ai Inc.	P Buy	2026-08-20	2026-08-24	1,125,000	$3.20	$3.60M	4,084,143	SEC↗
ODYS Odysight.ai Inc.	P Buy	2026-08-20	2026-08-24	1,125,000	$3.20	$3.60M	4,084,143	SEC↗
ODYS Odysight.ai Inc.	M Exercise deriv	2026-03-25	2026-03-27	2,352,941	—	$0	0	SEC↗
ODYS Odysight.ai Inc.	M Exercise	2026-03-25	2026-03-27	2,352,941	$5.50	$12.94M	4,705,882	SEC↗
ODYS Odysight.ai Inc.	F Tax w/h	2026-03-25	2026-03-27	2,081,044	$5.50	$11.45M	2,624,838	SEC↗
HOWL Werewolf Therapeutics, Inc	C Conversion deriv	2021-05-04	2021-05-04	10,714,284	—	$0	0	SEC↗
HOWL Werewolf Therapeutics, Inc	C Conversion deriv	2021-05-04	2021-05-04	3,560,551	—	$0	0	SEC↗
HOWL Werewolf Therapeutics, Inc	C Conversion	2021-05-04	2021-05-04	1,235,917	—	$0	1,235,917	SEC↗
HOWL Werewolf Therapeutics, Inc	C Conversion	2021-05-04	2021-05-04	410,717	—	$0	1,646,634	SEC↗
HOWL Werewolf Therapeutics, Inc	P Buy	2021-05-04	2021-05-04	400,000	$16.00	$6.40M	2,046,634	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	167,537	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	343,270	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	1,382,295	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	1,382,295	—	$0	1,382,295	SEC↗
KROS Keros Therapeutics, Inc.	P Buy	2020-04-13	2020-04-13	120,000	$16.00	$1.92M	2,013,102	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	343,270	—	$0	1,725,565	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	167,537	—	$0	1,893,102	SEC↗